HUP0104716A3 - Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them - Google Patents

Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them

Info

Publication number
HUP0104716A3
HUP0104716A3 HU0104716A HUP0104716A HUP0104716A3 HU P0104716 A3 HUP0104716 A3 HU P0104716A3 HU 0104716 A HU0104716 A HU 0104716A HU P0104716 A HUP0104716 A HU P0104716A HU P0104716 A3 HUP0104716 A3 HU P0104716A3
Authority
HU
Hungary
Prior art keywords
sarcosystis
neospora
toxoplasma
treating diseases
medicaments containing
Prior art date
Application number
HU0104716A
Other languages
English (en)
Original Assignee
Bayer Corp Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp Pittsburgh filed Critical Bayer Corp Pittsburgh
Publication of HUP0104716A2 publication Critical patent/HUP0104716A2/hu
Publication of HUP0104716A3 publication Critical patent/HUP0104716A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0104716A 1998-12-22 1999-12-17 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them HUP0104716A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21871298A 1998-12-22 1998-12-22
PCT/US1999/030284 WO2000037084A1 (en) 1998-12-22 1999-12-17 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Publications (2)

Publication Number Publication Date
HUP0104716A2 HUP0104716A2 (hu) 2002-04-29
HUP0104716A3 true HUP0104716A3 (en) 2003-10-28

Family

ID=22816194

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104716A HUP0104716A3 (en) 1998-12-22 1999-12-17 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them

Country Status (12)

Country Link
EP (1) EP1140101A1 (hu)
JP (1) JP2002532552A (hu)
KR (1) KR20010080571A (hu)
CN (1) CN1331595A (hu)
AU (1) AU2198100A (hu)
BR (1) BR9916417A (hu)
CA (1) CA2356181A1 (hu)
HK (1) HK1043065A1 (hu)
HU (1) HUP0104716A3 (hu)
NZ (1) NZ512476A (hu)
WO (1) WO2000037084A1 (hu)
ZA (1) ZA200103919B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1119255A4 (en) 1998-10-08 2009-04-15 New Ace Res Company NEW COMPOSITIONS AND METHOD FOR THE PREVENTION AND TREATMENT OF PROTOCOL DISEASES
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10040110A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
CN111819172B (zh) 2018-02-26 2024-02-06 阿泽克制药公司 用于治疗与神经营养蛋白有关的疾病的三嗪衍生物
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9808114A (pt) * 1997-03-31 2000-03-08 David Granstrom Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos

Also Published As

Publication number Publication date
KR20010080571A (ko) 2001-08-22
CA2356181A1 (en) 2000-06-29
WO2000037084A1 (en) 2000-06-29
ZA200103919B (en) 2002-05-15
BR9916417A (pt) 2001-11-06
CN1331595A (zh) 2002-01-16
NZ512476A (en) 2003-08-29
HUP0104716A2 (hu) 2002-04-29
EP1140101A1 (en) 2001-10-10
JP2002532552A (ja) 2002-10-02
HK1043065A1 (zh) 2002-09-06
AU2198100A (en) 2000-07-12

Similar Documents

Publication Publication Date Title
GB9801363D0 (en) Novel dosage form
GB9818732D0 (en) Collection of compounds
EP1073466A4 (en) SOLUTION CONTAINING NICOTIN
PL345901A1 (en) Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
GB9817118D0 (en) Pharmaceutical compounds
GB9817623D0 (en) Pharmaceutical compounds
HUP0104710A3 (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing the same
GB9810886D0 (en) Pharmaceutical compounds
HUP0104716A3 (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma and medicaments containing them
HUP0104595A3 (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
HUP0103303A3 (en) Imidazole compounds, process for producing them, their use and medicaments containing them
HUP0104620A3 (en) 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them
GB9823847D0 (en) Pharmaceutical compounds
GB9808665D0 (en) Therapeutic compounds
GB9823845D0 (en) Pharmaceutical compounds
HUP0103569A2 (hu) Új gyógyszerkészítmény és eljárás az előállítására
PL335668A1 (en) Shield
GB9828620D0 (en) Medicaments
GB9817197D0 (en) Pharmaceutical compounds
GB9827865D0 (en) Medicament
GB9808667D0 (en) Therapeutic compounds
TW355367U (en) Structure for safety syringe
GB9821694D0 (en) Amphiphilogel dosage form
ZA989425B (en) Dosage form
GB9826998D0 (en) Medicaments